PMGC (ELAB)
Operates packaging and precision-machining businesses alongside early-stage technology programs.
Something off on this page? Send us feedback.
Sells custom protective packaging and high-tolerance contract machining through an acquisition-led diversified holding company that also owns preclinical bioscience and early-stage defense technology programs. Revenue comes from direct custom packaging sales and machining orders, repeat work, and referrals.
Combines custom protective packaging with precision engineering and machining, while also housing early-stage bioscience, defense-technology, and investment activities. Pacific Sun Packaging designs and manufactures electrostatic-discharge protective packaging for computer components. AGA Precision, SVM Machining, and A&B Aerospace provide high-tolerance CNC machining for aerospace, defense, and industrial customers. Operations and assets are principally in the United States, with manufacturing operations in California.
Generates operating revenue from customized packaging and contract machining, with repeat work, referrals, and customer purchase orders supporting the manufacturing businesses. NorthStrive Biosciences' muscle-preservation candidates remain preclinical, and NorthStrive Defense Tech's licensed autonomous-vehicle technology remains in prototype and simulation-validation stages. Recent acquisitions require integration, while revenue and purchases remain concentrated among a limited group of customers and suppliers.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $18.8M · Total debt $13.9M · Total assets $36.6M · Shareholders' equity $16.7M
- Revenue
- $1.3M
- Operating income
- −$3.8M
- Net income
- −$2.9M
No dividends on record.
| Institutions | 5.87% | 26.7K shares | |
|---|---|---|---|
| 12 holders · as of Jun 30, 2026 | |||
| Other | 94.13% | 427.7K shares | |
| remainder | |||
454.4K company shares as of Aug 31, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (809.6K in the company's Sep 22, 2026 report, 454.4K elsewhere); stakes use the report.
3 positions filed across a stock split leave their adjustment unstated and stay out of the bar.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Jane Street Group, LLCInstitution | 1.79% | 81,501 | as of Jun 30, 2026 |
Morgan StanleyInstitution | 1.17% | 53,000 | as of Jun 30, 2026 |
Vanguard Fiduciary Trust CoInstitution | 0.75% | 34,014 | as of Jun 30, 2026 |
Geode Capital Management, LLCInstitution | 0.53% | 24,077 | as of Jun 30, 2026 |
Citadel Advisors LLCInstitution | 0.46% | 20,702 | as of Jun 30, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
- Ducommun
Aerospace and defense manufacturing rival for complex components.
- Howmet Aerospace
Scaled aerospace components and fasteners contest machining awards.
- UFP Technologies
Custom ESD protective packaging overlaps electronics-component shipping.
- Biohaven
Advanced myostatin-activin therapy targets fat loss and lean-mass gains.
- Scholar Rock
Anti-myostatin programs challenge the muscle-health therapeutic thesis.
- Novo Nordisk (ADR)
Wegovy and Ozempic dominate the GLP-1 obesity-treatment ecosystem.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| PMGC | $4.45 | +0.68% | $2.0M | — | — | 0.8 | — |
| Ducommun | $166.83 | −0.75% | $2.54B | — | 34.1 | 2.9 | +11.0% |
| Howmet Aerospace | $226.62 | −0.33% | $90.97B | 49.0 | 38.6 | 10.0 | +24.1% |
| UFP Technologies | $283.96 | +0.80% | $2.18B | 30.4 | 28.1 | 3.5 | +15.1% |
| Biohaven | $14.67 | +3.16% | $2.14B | — | — | — | — |
| Scholar Rock | $50.51 | +4.88% | $5.77B | — | — | — | — |
| Novo Nordisk (ADR) | $39.46 | −0.87% | $176.83B | 9.9 | 16.2 | 3.5 | +1.3% |
| Median | 30.4 | 31.1 | 3.5 | +13.0% |